Senior insider sale
Chief Executive Officer at SPYRE THERAPEUTICS, INC. — senior position signals high conviction
$2.20M
90K shares
What this filing means
TURTLE CAMERON plans to sell 90K shares of SPYRE THERAPEUTICS, INC. valued at approximately $2.20M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/3/2025ACC: 0001950047-25-008390
DirectorOfficer· Chief Executive Officer
Since Mar 2026
90K
Shares to sell
$2.20M
Approx. market value
90K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Previously Exercised Stock Options
Cash
6/15/2023
90KTotal acquired90K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/15/2023 | Previously Exercised Stock Options Cash | 90K | — |
| Total | 90K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
90K
Market value
$2.20M
11/3/2025
Total
Units
90K
Value
$2.20M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/3/2025 | 90K | $2.20M | NASDAQ | Planned |
| Total | 90K | $2.20M | ||